BioCentury | Aug 8, 2020
Management Tracks

PacBio shifts executive team; plus changes at CMAB, Valo, Alentis, Amwell and more

...CEO of Glycotope GmbH in 2016-18 and Immatics N.V. (NASDAQ:IMTX) in 2008-15. Fibrotic diseases company Alentis Therapeutics AG...
...of Eli Lilly and Co. (NYSE:LLY). BioCentury Staff Pacific Biosciences of California Inc. CMAB Biopharma (Suzhou) Inc. Valo Therapeutics Ltd. Alentis Therapeutics AG Selecta...
BioCentury | Apr 30, 2019
Finance

Why liver disease newco Alentis is aiming for one of largest Swiss A rounds

...series A for a Swiss biotech since 2015. Founded in the BaseLaunch incubator in Basel, Alentis Therapeutics AG...
Items per page:
1 - 2 of 2
BioCentury | Aug 8, 2020
Management Tracks

PacBio shifts executive team; plus changes at CMAB, Valo, Alentis, Amwell and more

...CEO of Glycotope GmbH in 2016-18 and Immatics N.V. (NASDAQ:IMTX) in 2008-15. Fibrotic diseases company Alentis Therapeutics AG...
...of Eli Lilly and Co. (NYSE:LLY). BioCentury Staff Pacific Biosciences of California Inc. CMAB Biopharma (Suzhou) Inc. Valo Therapeutics Ltd. Alentis Therapeutics AG Selecta...
BioCentury | Apr 30, 2019
Finance

Why liver disease newco Alentis is aiming for one of largest Swiss A rounds

...series A for a Swiss biotech since 2015. Founded in the BaseLaunch incubator in Basel, Alentis Therapeutics AG...
Items per page:
1 - 2 of 2